Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine and Glucocorticoids for Moderate/Severe COVID-19 in Elderly Patients
NCT04492358Phase 3Terminated
- Start
- Oct 2020
- Primary completion
- May 2021
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine, prednisone in coronavirus disease 2019 (COVID-19). Started Oct 2020; status: terminated.
02
Drugs
colchicineprednisone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04492358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04492358.